← SynDRA
SPIRAPRIL
SynDRA canonical compound SYN0000138 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ACE |
|---|
| Mechanism of action | angiotensin converting enzyme inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- HTR2B
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- KCNH2
- HTR1A
- ACHE
- HRH3
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- ADORA3
- TBXA2R
Drug classes
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- C09A · ACE INHIBITORS, PLAIN
Cross-references
Synonyms
- RENORMAX
- spirapril hydrochloride
- renormax
- spirapril HCl
- Espirapril
- Renormax
- Sandopril
- Setrilan
- Espirapril [Spanish]
- Not established
- Spiraprilum [Latin]
- Sch-33844
- Spirapril (INN)
- Spirapril [INN:BAN]
- TI-211-950
- Spiraprilum
- RefChem:184748
- DTXCID9024300
- C09AA11
- SPIRAPRIL [INN]
- BRN 4277924
- UNII-96U2K78I3V
- TI 211-950
- SPIRAPRIL [MI]
- SPIRAPRIL [WHO-DD]
- SCHEMBL17202
- GTPL6575
- orb1695170
- CHEBI:135756
- HRWCVUIFMSZDJS-SZMVWBNQSA-N
- HY-A0230
- BDBM50017124
- EBC-27166
- EX-A10472
- AKOS016013943
- CS-0017576
- D08529
- T34696
Look up SPIRAPRIL in the interactive SynDRA portal →